Micro Emerging Active

DXCM reports Q1 revenue growth

New narrative with limited coverage — still forming.

Score 0.2

Velocity ▲ 0.0

Articles 4

Sources 1

Top Movers

Ticker	Sector	Change
DXCM	Health Care	+16.0%

Sentiment Timeline

Sector Performance

Event Timeline

Jul 07, 2026 Earnings Preview: What To Expect From DexCom's Report Neutral

May 17, 2026 DexCom (DXCM) Posts Upbeat 2026, Climbs 6.6% Bullish

May 16, 2026 DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day Bullish

May 08, 2026 DexCom (DXCM) Reports Q1 2026 Revenue of $1.19B with 15% Growth Neutral

DexCom (DXCM) Posts Upbeat 2026, Climbs 6.6% Yahoo Finance · May 17, 2026 Mixed DexCom (DXCM) Reports Q1 2026 Revenue of $1.19B with 15% Growth Yahoo Finance · May 08, 2026 Mixed

Top Movers

Ticker	Sector	Change
DXCM	Health Care	+16.0%

🤖 AI Overview

What happened: On April 30, 2023, DexCom (DXCM) reported Q1 2023 revenue of $1.192 billion, up 15% year-over-year, driven by an 11% rise in US revenue and a 26% jump internationally. Following this, DXCM stock surged 6.6% on May 5, 2023, bolstered by its upbeat full-year outlook. At its investor day, DexCom outlined a long-term growth plan targeting over 10% annual revenue growth through 2030, along with margin expansion and a $1 billion share repurchase program.

Market impact: The medical device sector, particularly continuous glucose monitoring (CGM) companies, is affected. DexCom's strong performance and growth outlook drive investor confidence, leading to a revaluation of other CGM stocks like Abbott Laboratories (ABT) and Medtronic (MDT). The positive sentiment also impacts the broader healthcare sector, with ETFs like the Health Care Select Sector SPDR Fund (XLV) benefiting.

What to watch next: Investors should monitor DexCom's Q2 2023 earnings, scheduled for August 1, 2023, to confirm its growth trajectory. Additionally, they should keep an eye on the FDA's approval process for DexCom's G8 system, expected in late 2023, which could drive further growth. Lastly, the launch and adoption of DexCom's G7 system in Europe, slated for mid-2023, will indicate international growth potential.

AI Overview as of May 17, 2026

Timeline

First SeenJul 07, 2026

Last UpdatedOct 04, 2026

DXCM reports Q1 revenue growth

Top Movers

Sentiment Timeline

Sector Performance

Event Timeline

Related Articles